RFG Advisory LLC Boosts Stock Position in Procter & Gamble Company (The) $PG

RFG Advisory LLC grew its position in Procter & Gamble Company (The) (NYSE:PG) by 2.5% in the second quarter, Holdings Channel.com reports. The fund owned 43,568 shares of the company’s stock after buying an additional 1,058 shares during the period. RFG Advisory LLC’s holdings in Procter & Gamble were worth $6,941,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in PG. Kingstone Capital Partners Texas LLC increased its holdings in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Nuveen LLC bought a new stake in shares of Procter & Gamble in the 1st quarter valued at approximately $1,954,941,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after acquiring an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its holdings in shares of Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after acquiring an additional 1,674,139 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Trading Down 1.4%

NYSE:PG opened at $147.54 on Tuesday. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43. The stock has a market cap of $345.32 billion, a price-to-earnings ratio of 22.66, a PEG ratio of 3.97 and a beta of 0.36. The business has a fifty day moving average of $155.18 and a 200-day moving average of $159.27. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the prior year, the business posted $1.40 earnings per share. The company’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of recent research reports. Bank of America lowered their price objective on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Barclays lowered their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research note on Friday. BNP Paribas restated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Finally, Evercore ISI restated an “in-line” rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.

Insider Buying and Selling

In other news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares of the company’s stock, valued at approximately $28,689,507.94. The trade was a 5.12% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 149,763 shares of company stock valued at $23,421,279. Company insiders own 0.20% of the company’s stock.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.